Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Simulated amniotic fluid for NEC prevention in VLBW neonates
NCT02405637Phase 1Unknown
- Start
- Mar 2014
- Primary completion
- Mar 2015
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in necrotizing enterocolitis (NEC) and feeding intolerance (2 arms). Primary endpoints: Necrotizing enterocolitis at 2 months, Mortality at 2 months and 1 more. Status: unknown.
02
Conditions
necrotizing enterocolitis (NEC)feeding intolerance
Beyond the preview
Go deeper on NCT02405637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405637.